Ubs Oconnor LLC Acumen Pharmaceuticals, Inc. Transaction History

Ubs Oconnor LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.15 - $9.72 $41,500 - $97,200	-10,000 Reduced 12.57%	69,538 $288,000
Q2 2023 Aug 14, 2023	BUY	$3.59 - $6.59 $285,541 - $524,155	79,538 New	79,538 $383 Million
Q1 2023 May 15, 2023	BUY	$3.75 - $6.65 $29,707 - $52,681	7,922 Added 14.83%	61,358 $249,000
Q4 2022 Feb 14, 2023	BUY	$4.81 - $10.17 $257,027 - $543,444	53,436 New	53,436 $0

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.5M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.